AKR1B1 and diabetes mellitus: Morphological abnormalities in the corneal endothelium have been reported8,40 to improve after administration of an aldose reductase inhibitor in the polyol pathway, which supports its involvement in the corneal endothelial abnormalities of patients with DM.